flu vaccine related Press Releases
VaxInnate's Universal Flu Vaccine Candidate Shown Safe and Immunogenic in Phase I Clinical Study
VaxInnate's Universal Flu Vaccine Candidate Shown Safe and Immunogenic in Phase I Clinical Study Study validates proprietary technology that could transform flu vaccine production
... Read more...Better by design: Engineering flu vaccines
Better by design: Engineering flu vaccines New method could improve vaccines for both seasonal flu and bird flu HOUSTON -- (March 17, 2009) -- A new computerized method of testing could help world
... Read more...Intanza®, the First Intradermal Influenza Vaccine, receives the European Marketing Authorisation
Intanza®, the First Intradermal Influenza Vaccine, receives the European Marketing Authorisation Intanza®, the first seasonal flu vaccine delivered by intradermal microinjection, has been
... Read more...Juvaris BioTherapeutics Announces Positive Data from Clinical Trial of JVRS-100 Adjuvanted Flu Vaccine
Juvaris BioTherapeutics Announces Positive Data from Clinical Trial of JVRS-100 Adjuvanted Flu Vaccine BURLINGAME, Calif.--(BUSINESS WIRE)--Juvaris BioTherapeutics, Inc., a biotechnology company
... Read more...Baxter Receives EMEA Positive Opinion for CELVAPAN, The First Cell Culture-Based Pandemic Flu Vaccine
Baxter Receives EMEA Positive Opinion for CELVAPAN, The First Cell Culture-Based Pandemic Flu Vaccine Clinical data from a Phase III and subsequent booster study demonstrate safety, immune response
... Read more...SDI Reports: Number of Flu Vaccines Given in Physicians' Offices Lower This Season
SDI Reports: Number of Flu Vaccines Given in Physicians' Offices Lower This Season The Number of Vaccines Given After Thanksgiving Has Not Rebounded December 15, 2008 PLYMOUTH MEETING, Pa.--(BUSINESS
... Read more...GSK Major Seasonal Influenza Vaccine Efficacy Trial To Assess Superior Protection For Those At Risk Of Influenza
GSK Major Seasonal Influenza Vaccine Efficacy Trial To Assess Superior Protection For Those At Risk Of Influenza GlaxoSmithKline (GSK) announced today that it has started a worldwide clinical
... Read more...Pneumococcal Vaccine Could Prevent Numerous Deaths, Save Costs During A Flu Pandemic, Model Predicts
Pneumococcal Vaccine Could Prevent Numerous Deaths, Save Costs During A Flu Pandemic, Model Predicts (Oct. 31, 2008) - A new predictive model shows that vaccinating infants with 7 valent
... Read more...High dose of flu vaccine boosts immune response in elderly
High dose of flu vaccine boosts immune response in elderly October 26, 2008 Giving people age 65 and older a dose four times larger than the standard flu vaccine boosts the amount of antibodies in
... Read more...VaxInnate's Second Flu Vaccine Candidate Enters Clinical Development; Results Expected in Early 2009
VaxInnate's Second Flu Vaccine Candidate Enters Clinical Development; Results Expected in Early 2009 Study Tests Novel Technology with Potential to Transform Production of Flu Vaccines CRANBURY,... Read more...
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
